Sami Y Kalliney

Title: The Innovative Contributions of Sami Y Kalliney

Introduction

Sami Y Kalliney is a notable inventor based in Parsippany, NJ (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds with antibacterial properties. With a total of 3 patents to his name, Kalliney's work has the potential to impact medical treatments and drug development.

Latest Patents

Kalliney's latest patents include innovative processes for synthesizing quinoline 5-carboxamides, which are useful for the preparation of PDE IV inhibitors. This process highlights his expertise in creating compounds that can lead to advancements in therapeutic applications. Another notable patent involves the electrochemical method for preparing Everninomicin derivatives that are devoid of a nitro group and possess antibacterial activity. This method allows for the reduction of everninomicin compounds in an aprotic anhydrous solvent, resulting in a mixture of antibacterial agents.

Career Highlights

Kalliney is currently employed at Schering Corporation, where he continues to push the boundaries of pharmaceutical innovation. His work at the company has allowed him to collaborate with other talented professionals in the field, further enhancing his contributions to drug development.

Collaborations

Some of Kalliney's coworkers include Peter Kabasakalian and Anita Westcott. Their collaborative efforts have likely played a role in the successful development of Kalliney's patents and innovations.

Conclusion

Sami Y Kalliney is a distinguished inventor whose work in pharmaceuticals has led to the development of important antibacterial compounds. His patents reflect a commitment to innovation and a desire to improve medical treatments. Kalliney's contributions are a testament to the impact that dedicated inventors can have on the healthcare industry.